These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 2529385)
41. Increased secretion of brain natriuretic peptide and atrial natriuretic peptide, but not sufficient to induce natriuresis in rats with nephrotic syndrome. Yokota N; Yamamoto Y; Aburaya M; Kitamura K; Eto T; Kangawa K; Minamino N; Matsuo H; Tanaka K Biochem Biophys Res Commun; 1991 Jan; 174(1):128-35. PubMed ID: 1824917 [TBL] [Abstract][Full Text] [Related]
42. Comparison of renal actions of urodilatin and atrial natriuretic peptide. Hildebrandt DA; Mizelle HL; Brands MW; Hall JE Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650 [TBL] [Abstract][Full Text] [Related]
43. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942 [TBL] [Abstract][Full Text] [Related]
44. Dehydration increases the renal response to atrial natriuretic peptide in fetal sheep. Dodd A; Chan K; Kullama LK; Ervin MG; Ross MG Am J Obstet Gynecol; 1992 Dec; 167(6):1710-6. PubMed ID: 1471688 [TBL] [Abstract][Full Text] [Related]
45. Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man. Weidmann P; Hellmueller B; Uehlinger DE; Lang RE; Gnaedinger MP; Hasler L; Shaw S; Bachmann C J Clin Endocrinol Metab; 1986 May; 62(5):1027-36. PubMed ID: 2937799 [TBL] [Abstract][Full Text] [Related]
46. Effects of human atrial natriuretic peptide on renal function and vasopressin release. Kimura T; Abe K; Shoji M; Tsunoda K; Matsui K; Ota K; Inoue M; Yasujima M; Yoshinaga K Am J Physiol; 1986 May; 250(5 Pt 2):R789-94. PubMed ID: 2939732 [TBL] [Abstract][Full Text] [Related]
47. Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension. Hirata Y; Ishii M; Sugimoto T; Matsuoka H; Fukui K; Sugimoto T; Yamakado M; Tagawa H; Miyata A; Kangawa K Circulation; 1988 Dec; 78(6):1401-10. PubMed ID: 2847885 [TBL] [Abstract][Full Text] [Related]
48. Plasma atrial natriuretic peptide and natriuretic response to water immersion in patients with nephrotic syndrome. Hwang SJ; Tsai JH; Lai YH; Chen JH Nephron; 1991; 58(3):330-8. PubMed ID: 1832746 [TBL] [Abstract][Full Text] [Related]
49. Effects of sodium intake, furosemide, and infusion of atrial natriuretic peptide on the urinary and metabolic clearances of arginine vasopressin in normal subjects. Moses AM; Jones C; Yucha CB J Clin Endocrinol Metab; 1990 Jan; 70(1):222-9. PubMed ID: 2136743 [TBL] [Abstract][Full Text] [Related]
51. Atrial natriuretic peptide induces sustained natriuresis in conscious dogs. Mizelle HL; Hildebrandt DA; Gaillard CA; Brands MW; Montani JP; Smith MJ; Hall JE Am J Physiol; 1990 Jun; 258(6 Pt 2):R1445-52. PubMed ID: 2141770 [TBL] [Abstract][Full Text] [Related]
52. Preferential increase in the free form of atrial natriuretic peptide in adriamycin-induced nephrotic rats. Yokota N; Kato J; Yamamoto Y; Kitamura K; Kida O; Eto T; Tanaka K Nephron; 1991; 59(1):61-5. PubMed ID: 1834955 [TBL] [Abstract][Full Text] [Related]
53. Renal response of anesthetized rats to low-dose infusion of atrial natriuretic peptide. Soejima H; Grekin RJ; Briggs JP; Schnermann J Am J Physiol; 1988 Sep; 255(3 Pt 2):R449-55. PubMed ID: 2970807 [TBL] [Abstract][Full Text] [Related]
54. Diuretic response of a second infusion of atrial natriuretic polypeptide into anesthetized dogs. Akabane S; Matsushima Y; Kawamura M; Kojima S; Ito K Nephron; 1987; 45(2):135-9. PubMed ID: 2951604 [TBL] [Abstract][Full Text] [Related]
55. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension. Franco-Saenz R; Somani P; Mulrow PJ Am J Hypertens; 1992 May; 5(5 Pt 1):266-75. PubMed ID: 1533767 [TBL] [Abstract][Full Text] [Related]
56. Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man. Anderson JV; Donckier J; Payne NN; Beacham J; Slater JD; Bloom SR Clin Sci (Lond); 1987 Mar; 72(3):305-12. PubMed ID: 2949910 [TBL] [Abstract][Full Text] [Related]
57. ANP-mediated volume depletion attenuates renal responses in humans. Ebert TJ; Groban L; Muzi M; Hanson M; Cowley AW Am J Physiol; 1992 Dec; 263(6 Pt 2):R1303-8. PubMed ID: 1481943 [TBL] [Abstract][Full Text] [Related]
58. Effect of vasopressin on atrial natriuretic peptide release and renal function in dogs. Inoue M; Kimura T; Ota K; Iitake K; Shoji M; Sato K; Ota M; Yoshinaga K Am J Physiol; 1988 Oct; 255(4 Pt 1):E449-55. PubMed ID: 2972212 [TBL] [Abstract][Full Text] [Related]
59. Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome. Kinoshita H; Fujimoto S; Fukae H; Yokota N; Hisanaga S; Nakazato M; Eto T Nephron; 1999 Feb; 81(2):160-4. PubMed ID: 9933751 [TBL] [Abstract][Full Text] [Related]
60. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate. Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB Nephron; 1995; 71(1):44-53. PubMed ID: 8538848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]